Works matching DE "HETEROZYGOUS familial hypercholesterolemia"
Results: 78
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 119, doi. 10.1007/s10557-022-07386-0
- By:
- Publication type:
- Article
An Interesting Case of Neonatal Atypical Hemolytic-Uremic Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 809, doi. 10.3390/biom12060809
- By:
- Publication type:
- Article
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 562, doi. 10.3390/biom12040562
- By:
- Publication type:
- Article
Older Familial Hypercholesterolemia Patients with COVID-19.
- Published in:
- Gerontology, 2021, v. 67, n. 5, p. 608, doi. 10.1159/000514447
- By:
- Publication type:
- Article
Familial hypercholesterolemia due to an heterozygous LDLR promoter mutation: a case report.
- Published in:
- Médicas UIS, 2024, v. 37, n. 3, p. 71, doi. 10.18273/revmed.v37n3-2024007
- By:
- Publication type:
- Article
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 4, p. 373, doi. 10.1007/s40273-023-01347-7
- By:
- Publication type:
- Article
Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund.
- Published in:
- Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej, 2022, v. 18, n. 2, p. 162, doi. 10.5114/aic.2022.118533
- By:
- Publication type:
- Article
Monoclonal Anti-PCSK9 Antibodies: Real-World Data.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4543, doi. 10.3390/jcm13154543
- By:
- Publication type:
- Article
Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2270, doi. 10.3390/jcm13082270
- By:
- Publication type:
- Article
Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 483, doi. 10.3390/jcm12020483
- By:
- Publication type:
- Article
Cardiovascular Risk Factors in Childhood and Adolescence.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041136
- By:
- Publication type:
- Article
Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5867, doi. 10.3390/jcm10245867
- By:
- Publication type:
- Article
Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3494, doi. 10.3390/jcm10163494
- By:
- Publication type:
- Article
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2144, doi. 10.3390/biomedicines10092144
- By:
- Publication type:
- Article
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071715
- By:
- Publication type:
- Article
Recent Advances on Familial Hypercholesterolemia in Children and Adolescents.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1043, doi. 10.3390/biomedicines10051043
- By:
- Publication type:
- Article
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 771, doi. 10.3390/biomedicines10040771
- By:
- Publication type:
- Article
Impacto de un cribado oportunista de hipercolesterolemia familiar (estudio CRIBACOL) en el area sanitaria de Vigo.
- Published in:
- Galicia Clínica, 2022, v. 83, n. 3, p. 28, doi. 10.22546/66/2680
- By:
- Publication type:
- Article
Case report: Heterozygous Familial Hypercholesterolemia (HeFH).
- Published in:
- 2012
- By:
- Publication type:
- Case Study
An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia.
- Published in:
- Pediatric Cardiology, 2011, v. 32, n. 4, p. 433, doi. 10.1007/s00246-011-9885-z
- By:
- Publication type:
- Article
Systematic Review and Metaanalysis of Statins for Heterozygous Familial Hypercholesterolemia in Children: Evaluation of Cholesterol Changes and Side Effects.
- Published in:
- Pediatric Cardiology, 2009, v. 30, n. 4, p. 482, doi. 10.1007/s00246-008-9364-3
- By:
- Publication type:
- Article
Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis.
- Published in:
- Current Medical Research & Opinion, 2022, v. 38, n. 5, p. 777, doi. 10.1080/03007995.2022.2049164
- By:
- Publication type:
- Article
Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book.
- Published in:
- European Heart Journal, 2023, v. 44, n. 2, p. 139, doi. 10.1093/eurheartj/ehac656
- By:
- Publication type:
- Article
Inclisiran in primary prevention: reality or fiction?
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5058, doi. 10.1093/eurheartj/ehac653
- By:
- Publication type:
- Article
Underdiagnosis of familial hypercholesterolaemia: innovation is overdue.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3255, doi. 10.1093/eurheartj/ehab869
- By:
- Publication type:
- Article
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
- Published in:
- European Heart Journal, 2021, v. 42, n. 32, p. 3063, doi. 10.1093/eurheartj/ehab424
- By:
- Publication type:
- Article
Current causes of death in familial hypercholesterolemia.
- Published in:
- Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01671-5
- By:
- Publication type:
- Article
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study.
- Published in:
- Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01666-2
- By:
- Publication type:
- Article
Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey.
- Published in:
- Lipids in Health & Disease, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12944-021-01467-z
- By:
- Publication type:
- Article
Skin microcirculation significantly increases after lipoprotein apheresis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2023, v. 27, n. 4, p. 823, doi. 10.1111/1744-9987.13976
- By:
- Publication type:
- Article
Comparison of plasma separation using centrifugation or filtration for MONET lipoprotein apheresis in patients with cardiovascular disease and severe dyslipidemia.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1281, doi. 10.1111/1744-9987.13840
- By:
- Publication type:
- Article
Failure of lipid control by PCSK9 inhibitors in compound heterozygous familial hypercholesterolemia complicated with premature myocardial infarction: A case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
PD11 Cost-Effectiveness Analysis Of Inclisiran For Treating Primary Hypercholesterolemia And Mixed Dyslipidemia In Singapore.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Alirocumab: Pediatric First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158964
- By:
- Publication type:
- Article
Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019.
- Published in:
- ClinicoEconomics & Outcomes Research, 2022, v. 14, p. 189, doi. 10.2147/CEOR.S347085
- By:
- Publication type:
- Article
Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care.
- Published in:
- American Journal of Case Reports, 2023, v. 24, p. 1, doi. 10.12659/AJCR.939489
- By:
- Publication type:
- Article
Familial Hypercholesterolemia: Screening, Diagnosis, and Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02797-8
- By:
- Publication type:
- Article
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN).
- Published in:
- Journal of Internal Medicine, 2022, v. 291, n. 5, p. 702, doi. 10.1111/joim.13421
- By:
- Publication type:
- Article
Long-term retainment of some chromosomal inversions in a local population of Belgica antarctica Jacobs (Diptera, Chironomidae).
- Published in:
- Czech Polar Reports, 2021, v. 11, n. 1, p. 16, doi. 10.5817/CPR2021-1-3
- By:
- Publication type:
- Article
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity.
- Published in:
- Pediatric Nephrology, 2018, v. 33, n. 7, p. 1199, doi. 10.1007/s00467-018-3906-6
- By:
- Publication type:
- Article
Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4831, doi. 10.3390/ijms25094831
- By:
- Publication type:
- Article
Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1637, doi. 10.3390/ijms25031637
- By:
- Publication type:
- Article
Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15308, doi. 10.3390/ijms242015308
- By:
- Publication type:
- Article
Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14065, doi. 10.3390/ijms232214065
- By:
- Publication type:
- Article
Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2006, v. 174, n. 8, p. 1124, doi. 10.1503/cmaj.051313
- By:
- Publication type:
- Article
МОНА ЛИЗА В НАШЕТО СЪВРЕМИЕ: ПАЦИЕНТ С ФАМИЛНА ХЕТЕРОЗИГОТНА ХИПЕРХОЛЕСТЕРОЛЕМИЯ.
- Published in:
- General Medicine / Obsta Medicina, 2022, v. 24, n. 4, p. 39
- By:
- Publication type:
- Article
МОНА ЛИЗА В НАШЕТО СЪВРЕМИЕ: ПАЦИЕНТ С ФАМИЛНА ХЕТЕРОЗИГОТНА ХИПЕРХОЛЕСТЕРОЛЕМИЯ.
- Published in:
- General Medicine / Obsta Medicina, 2022, v. 24, n. 4, p. 39
- By:
- Publication type:
- Article